SGK
RMD icon

Steigerwald Gordon & Koch’s ResMed RMD Stock Holding History

Steigerwald Gordon & Koch’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2K Hold
50
– – ﹤0.01% 510
2025
Q4 		$12K Hold
50
– – ﹤0.01% 537
2025
Q3 		$13.7K Buy
+50
New +$13.7K ﹤0.01% 485

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steigerwald Gordon & Koch's RMD Position: Q1 2026 in Review

Steigerwald Gordon & Koch held its ResMed (RMD) position steady in Q1 2026 at 50 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

Steigerwald Gordon & Koch first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $13.7K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Steigerwald Gordon & Koch held 50 shares of ResMed worth $11.2K as of Q1 2026.
  • Steigerwald Gordon & Koch left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q1 2026, its #510 holding.
  • Steigerwald Gordon & Koch first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Steigerwald Gordon & Koch's ResMed position peaked at $13.7K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.